EUVIMEDEUVIMED entdecken
Crossref

Changing care for patients at risk for Huntington's disease in the United States due to the 21st Century Cures Act

Abigayle E Rose iD, Victoria Klee iD, Maysen Mesaros iD, Dawn C Allain iD

Journal of Genetic Counseling · 2026-06 · 35 (3)

DOI: 10.1002/jgc4.70217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Genetic Counseling, online erschienen am 15.05.2026. Verfasst von Abigayle E Rose und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Huntington Disease, Genetic Testing. Die Arbeit nennt 17 Literaturangaben. Gefördert von: National Society of Genetic Counselors.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Huntington's Disease Society of America (HDSA) protocol requires in‐person result disclosure for predictive testing due to the increased suicidality risk in the Huntington's disease (HD) population. The 21st Century Cures Act (Cures), a United States law requiring immediate release of all healthcare test results, contradicts this protocol. There is no published literature exploring how Cures has impacted HDSA centers of excellence (CoE). This study used semi‐structured interviews with 15 HDSA CoE healthcare professionals (HCPs) to explore the impact of Cures on the HDSA CoE's disclosure of predictive HD test results. Interviews were recorded, transcribed, and coded to identify recurring categories via inductive content analysis. Two‐thirds of participants reported changes made due to Cures. Three major categories were identified: changes made, changes wished for, and concerns regarding immediate release of predictive HD test results. There was variability among reported workflow changes. The most requested change was embargoing release of HD results due to concerns about patient result misinterpretation, suicidality, and survivor's guilt. Published guidelines on how to navigate immediate release of HD genetic testing results could provide a standardized approach across HDSA CoE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseGenetic TestingHumansUnited States

Stichwörter der Autor:innen

Cures actHuntington diseasedisclosuregenetic testingmedical legislation

Autor:innen und Institutionen

  • Department of Internal Medicine, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Medical University of South Carolina, Charleston, South Carolina, USA.

ORCID-Profile: Abigayle E Rose, Victoria Klee, Maysen Mesaros, Dawn C Allain

Förderung

  • National Society of Genetic Counselors

Zitieren

APA

Rose, A. E., Klee, V., Mesaros, M., & Allain, D. C. (2026). Changing care for patients at risk for Huntington's disease in the United States due to the 21st Century Cures Act. Journal of Genetic Counseling, 35(3). https://doi.org/10.1002/jgc4.70217

Vancouver

Rose AE, Klee V, Mesaros M, Allain DC. Changing care for patients at risk for Huntington's disease in the United States due to the 21st Century Cures Act. Journal of Genetic Counseling. 2026;35(3). doi:10.1002/jgc4.70217

BibTeX
@article{Rose2026,
  author = {Rose, Abigayle E and Klee, Victoria and Mesaros, Maysen and Allain, Dawn C},
  title = {Changing care for patients at risk for Huntington's disease in the United States due to the 21st Century Cures Act},
  journal = {Journal of Genetic Counseling},
  year = {2026},
  volume = {35},
  number = {3},
  doi = {10.1002/jgc4.70217}
}
Kostenlos starten →